Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
- PMID: 36845218
- PMCID: PMC9947926
- DOI: 10.15420/ecr.2022.11
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
Abstract
Artificial intelligence (AI) is a broad term referring to any automated systems that need 'intelligence' to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the dissemination of cardiovascular risk factors and the better prognosis of patients experiencing cardiovascular events resulted in an increase in the prevalence of cardiovascular disease (CVD), eliciting the need for precise identification of patients at increased risk for development and progression of CVD. AI-based predictive models may overcome some of the limitations that hinder the performance of classic regression models. Nonetheless, the successful application of AI in this field requires knowledge of the potential pitfalls of the AI techniques, to guarantee their safe and effective use in daily clinical practice. The aim of the present review is to summarise the pros and cons of different AI methods and their potential application in the cardiovascular field, with a focus on the development of predictive models and risk assessment tools.
Keywords: Artificial intelligence; cardiovascular disease; machine learning; risk prediction.
Copyright © 2022, Radcliffe Cardiology.
Conflict of interest statement
Disclosure: GS reports grants from Boston Scientific and consulting fees from Abbott Vascular, Boston Scientific and Pfizer/BMS. All other authors have no conflicts of interest to declare.
Figures
Similar articles
-
Clinical Application of Machine Learning-Based Artificial Intelligence in the Diagnosis, Prediction, and Classification of Cardiovascular Diseases.Circ J. 2021 Aug 25;85(9):1416-1425. doi: 10.1253/circj.CJ-20-1121. Epub 2021 Apr 22. Circ J. 2021. PMID: 33883384 Review.
-
Application of Artificial Intelligence in Acute Coronary Syndrome: A Brief Literature Review.Adv Ther. 2021 Oct;38(10):5078-5086. doi: 10.1007/s12325-021-01908-2. Epub 2021 Sep 15. Adv Ther. 2021. PMID: 34528221 Review.
-
Application of Artificial Intelligence in Pharmaceutical and Biomedical Studies.Curr Pharm Des. 2020;26(29):3569-3578. doi: 10.2174/1381612826666200515131245. Curr Pharm Des. 2020. PMID: 32410553 Review.
-
Artificial Intelligence and Machine Learning in Cardiovascular Health Care.Ann Thorac Surg. 2020 May;109(5):1323-1329. doi: 10.1016/j.athoracsur.2019.09.042. Epub 2019 Nov 7. Ann Thorac Surg. 2020. PMID: 31706869 Review.
-
Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease.Eur Heart J. 2022 Aug 14;43(31):2921-2930. doi: 10.1093/eurheartj/ehac238. Eur Heart J. 2022. PMID: 35639667 Free PMC article.
Cited by
-
QTc interval prolongation impact on in-hospital mortality in acute coronary syndromes patients using artificial intelligence and machine learning.Egypt Heart J. 2024 Nov 13;76(1):149. doi: 10.1186/s43044-024-00581-4. Egypt Heart J. 2024. PMID: 39535656 Free PMC article.
-
Development and validation of a cardiovascular risk prediction model for Sri Lankans using machine learning.PLoS One. 2024 Oct 22;19(10):e0309843. doi: 10.1371/journal.pone.0309843. eCollection 2024. PLoS One. 2024. PMID: 39436892 Free PMC article.
-
Pitfalls in Developing Machine Learning Models for Predicting Cardiovascular Diseases: Challenge and Solutions.J Med Internet Res. 2024 Jul 26;26:e47645. doi: 10.2196/47645. J Med Internet Res. 2024. PMID: 38869157 Free PMC article.
-
Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review.Pharmgenomics Pers Med. 2023 Nov 3;16:973-990. doi: 10.2147/PGPM.S391400. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 37941790 Free PMC article. Review.
-
From Research to Practice: The Future of Cardiovascular Care.Cureus. 2025 May 20;17(5):e84473. doi: 10.7759/cureus.84473. eCollection 2025 May. Cureus. 2025. PMID: 40539193 Free PMC article. Review.
References
-
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71. doi: 10.1016/S0140-6736(14)61682-2. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous